Voyager Therapeutics (VYGR) Profit After Tax: 2015-2025
Historic Profit After Tax for Voyager Therapeutics (VYGR) over the last 11 years, with Sep 2025 value amounting to -$27.9 million.
- Voyager Therapeutics' Profit After Tax fell 208.40% to -$27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$126.8 million, marking a year-over-year decrease of 589.88%. This contributed to the annual value of -$65.0 million for FY2024, which is 149.12% down from last year.
- Per Voyager Therapeutics' latest filing, its Profit After Tax stood at -$27.9 million for Q3 2025, which was up 16.45% from -$33.4 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Profit After Tax ranged from a high of $124.0 million in Q1 2023 and a low of -$34.5 million during Q4 2024.
- In the last 3 years, Voyager Therapeutics' Profit After Tax had a median value of -$22.2 million in 2023 and averaged -$2.3 million.
- Per our database at Business Quant, Voyager Therapeutics' Profit After Tax tumbled by 513.84% in 2022 and then surged by 681.85% in 2023.
- Quarterly analysis of 5 years shows Voyager Therapeutics' Profit After Tax stood at $5.7 million in 2021, then slumped by 513.84% to -$23.6 million in 2022, then soared by 338.70% to $56.4 million in 2023, then slumped by 161.15% to -$34.5 million in 2024, then tumbled by 208.40% to -$27.9 million in 2025.
- Its last three reported values are -$27.9 million in Q3 2025, -$33.4 million for Q2 2025, and -$31.0 million during Q1 2025.